Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
Clinical trial NCT02992301 · UNKNOWN
Trial details
- NCT number
- NCT02992301
- Sponsor
- Westside Medical Associates of Los Angeles
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2019-11-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.